The patients with clinically isolated syndrome and relapsing remitting multiple sclerosis show different levels of advanced protein oxidation products and total thiol content in plasma and CSF

Neurochemistry International

Volumn 62, Issue 7, 2013, Pages 988-997

  Ljubisavljevic, Srdjan ^a,b   Stojanovic, Ivana ^b   Vojinovic, Slobodan ^a   Stojanov, Dragan ^a   Stojanovic, Svetlana ^b   Cvetkovic, Tatjana ^b   Savic, Dejan ^a   Pavlovic, Dusica ^b  

^a CLINICAL CENTER NI   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

Author keywords

AOPP; Clinically isolated syndrome; EDSS; MRI; Relapsing remitting multiple sclerosis; SH groups

Indexed keywords

ADVANCED PROTEIN OXIDATION PRODUCT; ALBUMIN; GADOBUTROL; PROTEIN; PROTEIN DERIVATIVE; THIOL GROUP; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMYELINATING DISEASE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL;

ADULT; ADVANCED OXIDATION PROTEIN PRODUCTS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEURODEGENERATIVE DISEASES; SULFHYDRYL COMPOUNDS; SYNDROME; YOUNG ADULT;

EID: 84875985163     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.02.025     Document Type: Article

References (41)

1. G.N. Bisaga, M.M. Odinak, and A.N. Boiko Treatment of exacerbations of multiple sclerosis without the use of corticosteroids: the role of metabolic and antioxidant therapy Neurosci. Behav. Physiol. 42 2 2012 123 127
2. V. Calabrese, R. Bella, and D. Testa Increased cerebroespinal fluid and plasma levels of ultraweak chemiluminescence are associated with changes in the thiol pool and lipid soluble fluorescence in MS: the pathogenic role of oxidative stress Drugs Exp. Clin. Res. 24 1998 125 131
3. V. Calabrese, G. Scapagnini, and A. Ravagna Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine Neurochem. Res. 28 9 2003 1321 1328
4. A.H. Cross, P.T. Manning, and M.K. Stern Evidence for the production of peroxynitrite in inflammatory CNS demyelination J. Neuroimmunol. 80 1997 121 130
5. C.A. Dalton, P.A. Brex, and K.A. Miszkiel Application of the new mcdonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis Ann. Neurol. 52 2002 47 53
6. U. Davies Protein damage and degradation by oxygen radicals. I. General aspects J. Biol. Chem. 262 1987 9895 9901
7. U. Davies, S. Un, and R. Paciiici Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein J. Biol. Chem. 262 1987 9914 9920
8. O. Fernandez, and P. Vermersch From the fundamentals of multiple sclerosis to clinical management J. Neurol. Sci. 311 2011 S1 S2
9. E.M. Frohman, M.K. Racke, and C.S. Raine Multiple sclerosis - the plaque and its pathogenesis N. Engl. J. Med. 354 2006 942 955
10. P. Ghafourifar, K. Mousavizadeh, and M.S. Parihar Mitochondria in multiple sclerosis Front. Biosci. 13 2008 3116 3126
11. Y. Gilgun-Sherki, E. Melamed, and D. Offen The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy J. Neurol. 251 2004 261 268
12. J.J. Graber, and S. Dhib-Jalbut Biomarkers of disease activity in multiple sclerosis J. Neurol. Sci. 305 2011 1 10
13. S.J. Heales, S.E. Davies, and T.E. Bates Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration Neurochem. Res. 20 1995 31 38
14. J.W. Heinecke, W. Li, and H.D. Daehnke Dityrosine, a specific marker of oxidation, in synthesized by the myeloperoxidase hydrogen peroxide system of human neutrophils and macrophages J. Biol. Chem. 268 1993 4069 4077
15. M.L. Hu Measurement of protein thiol groups and glutathione in plasma J.N. Abelson, M.I. Simon, Methods in Enzymology 1994 Academic Press California 380 382
16. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1983 1444 1452
17. S. Ljubisavljevic, I. Stojanovic, and R. Pavlovic The reduced glutathione and S Nitrosothiols levels in acute phase of experimental demyelination - pathophysiological approach and possible clinical relevancy Neuroscience 219 2012 175 182
18. A. Lorber, C.M. Pearson, and W.L. Meredith Serum sulfhydryl determinations and significance in connective tissue diseases Ann. Intern. Med. 61 1964 423 434
19. F.D. Lublin, and S.C. Reingold Defining the clinical course of multiple sclerosis: results of an international survey - national multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis Neurology 46 1996 907 911
20. M. Lucas, M.C. Rodríguez, and J.M. Gata Regulation by interferon beta-1a of reactive oxygen metabolites production by lymphocytes and monocytes and serum sulfhydryls in relapsing multiple sclerosis patients Neurochem. Int. 42 2003 67 71
21. C. Lucchinetti, W. Brück, and J. Parisi Heterogeneity of multiple sclerosis lesions: implication for the pathogenesis of demyelination Ann. Neurol. 47 2000 707 717
22. A. Mirshafiey Venom therapy in multiple sclerosis Neuropharmacology. 53 2007 353 361
23. A. Mirshafiey, and M. Mohsenzadegan Antioxidant therapy in multiple sclerosis Immunopharmacol. Immunotoxicol. 31 1 2009 13 29
24. K. Mitosek-Szewczyk, W. Gordon-Krajcer, and P. Walendzik Free radical peroxidation products in cerebrospinal fluid and serum of patients with multiple sclerosis after glucocorticoid therapy Folia Neuropathol. 48 2 2010 116 122
25. J.H. Noseworthy, C. Lucchinetti, and M. Rodriguez Multiple sclerosis N. Engl. J. Med. 343 2000 938 952
26. S.R. Oliveira, A.P. Kallaur, and A.N.C. Simao Oxidative stress in multiple sclerosis patients in clinical remission: association with the expanded disability status scale J. Neurol. Sci. 321 1-2 2012 49 53
27. B. Park, S. Lee, and E. Kim Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing Cell 127 2006 369 382
28. G. Pentón-Rol, M. Cervantes-Llanos, and G. Martínez- Sánchez TNF-α and IL-10 downregulation and marked oxidative stress in Neuromyelitis Optica J. Inflamm. 6 2009 18
29. C.H. Polman, S.C. Reingold, and B. Banwell Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria Ann. Neurol. 69 2 2011 292 302
30. K. Rejdak, A. Petzold, and Z. Stelmasiak Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis Mult. Scler. 14 2008 59 66
31. S.R. Ruuls, J. Bauer, and K. Sontrop Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats J. Neuroimmunol. 56 1995 207 217
32. G. Scapagnini, R. Foresti, and V. Calabrese Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-l inducers Mol. Pharmacol. 61 2002 554 561
33. J. Sedlak, and R.H. Lindsay Estimation of total protein bound and non-protein sulfhydryl groups in tissue with Ellman's reagent Anal. Biochem. 25 1968 192 205
34. K.J. Smith, R. Kapoor, and P.A. Felts Demyelination: the role of reactive oxygen and nitrogen species Brain Pathol. 9 1999 69 92
35. M. Soszynski, and G. Bartosz Decrease in accessible thiols as an index of oxidative damage to membrane proteins Free Radic. Biol. Med. 23 1997 463 469
36. A. Staron, G. Makosa, and M. Koter-Michalak Oxidative stress in erythrocytes from patients with rheumatoid arthritis Rheumatol. Int. 32 2012 331 334
37. I. Stojanovic, S. Vojinovic, and S. Ljubisavljevic INF-β1b therapy modulates L-arginine and nitric oxide metabolism in patients with relapse remittens multiple sclerosis J. Neurol. Sci. 323 2013 187 192
38. M.P. Stoop, V. Singh, and L.J. Dekker Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis PLoS One 5 2010 e12442
39. J. van Horssen, G. Schreibelt, and L. Bo NAD(P)H:quinine oxidoreductase 1 expression in multiple sclerosis lesions Free Radic. Biol. Med. 41 2006 311 317
40. V. Witko Sarsat, T. Nguyen-Khoa, and P. Jungers Advanced oxidation protein product as a novel molecular basis of oxidative stress in uraemia Nephrol. Dial. Transplant. 14 1 1999 76 78
41. V. Witko-Sarsat, M. Friedlander, and C. Capeillere-Blandin Advanced oxidation protein products as a novel marker of oxidative stress in uremia Kidney Int. 49 1996 1304 1313